Target intelligence / Profile preview

DNA topoisomerase-DNA cleavage complex (Topo-DNA CC) (Topo-DNA CC)

Target
Topo-DNA CC
Molecular classification
Enzyme, DNA-binding protein complex, DNA topoisomerase
01

Overview

The DNA topoisomerase-DNA cleavage complex is a transient, covalent intermediate formed during the catalytic cycle of topoisomerase enzymes as they resolve topological strain in DNA (Pommier, 2013). These enzymes are essential for processes such as DNA replication, transcription, and chromosome segregation by creating temporary single- or double-strand breaks (Nitiss, 2009). In the context of oncology, this complex is the specific target of topoisomerase poisons, which trap the enzyme on the DNA, preventing the religation of the phosphodiester backbone (StatPearls, 2023). When the replication machinery or RNA polymerase encounters these stabilized complexes, it leads to the formation of permanent, lethal DNA double-strand breaks (Pommier, 2013). Tumor cells are often more susceptible to this damage due to their rapid proliferation rates and potential defects in DNA repair pathways (NIH, 2022). Consequently, targeting this complex remains a cornerstone of chemotherapy for various solid tumors and hematological malignancies (Nitiss, 2009). The stabilization of this complex is distinct from catalytic inhibition, as it converts an essential enzyme into a cellular toxin (Pommier, 2013). Clinical efficacy is often limited by the development of resistance mechanisms, such as the upregulation of repair enzymes like tyrosyl-DNA phosphodiesterase 1 (Delgado et al., 2018).

Other names
Topoisomerase cleavage complexTopoCCTopoisomerase-DNA covalent complexTopoisomerase-DNA adductTopoisomerase-DNA intermediate
02

Mechanism of action

Stabilization of the transient covalent intermediate formed between topoisomerase enzymes and DNA, preventing the religation of DNA strands and leading to lethal double-strand breaks during replication (Pommier, 2013; StatPearls, 2023).

03

Biological functions

DNA replicationDNA transcriptionChromosome segregationDNA repairChromatin remodeling
04

Disease associations

Cancer
05

Safety considerations

MyelosuppressionGastrointestinal toxicityCardiotoxicitySecondary malignancies
06

Interacting drugs

Irinotecan

8 more in the full profile.

07

Biomarkers

TOP1 expressionTOP2A expressionTyrosyl-DNA phosphodiesterase 1 (TDP1) levelsGamma-H2AX levels

Beyond the preview

Go deeper on DNA topoisomerase-DNA cleavage complex (Topo-DNA CC) (Topo-DNA CC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA topoisomerase-DNA cleavage complex (Topo-DNA CC) (Topo-DNA CC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call